Mark Litzow
Professor of medicine in the Division of Hematology at the Mayo Clinic; expert in acute lymphoblastic leukemia and author of the review on incorporation of immunotherapy into frontline treatment for B‑cell precursor ALL.
Best podcasts with Mark Litzow
Ranked by the Snipd community
Sep 18, 2025 • 13min
Review Series on Acute Lymphoblastic Leukemia (ALL)
Dr. Mark Litzow, a leading hematology professor from the Mayo Clinic, discusses groundbreaking immunotherapy advancements for Acute Lymphoblastic Leukemia (ALL). He highlights the impressive clinical trial results of treatments like blinatumomab and inotuzumab, boasting high remission rates and improved survival, especially among older patients. The conversation emphasizes the shift towards personalized, less toxic therapies, aiming to enhance patient outcomes and reduce chemotherapy intensity. This innovative approach could revolutionize ALL treatment, offering renewed hope for many.
Sep 25, 2024 • 18min
A focus on pediatric leukemias: trials, treatments, & challenges
Michele Redell, a physician at Texas Children’s Cancer Center, and Mark Litzow from Mayo Clinic, dive into the complexities of pediatric leukemias. They discuss the Pediatric Acute Leukemia Screening Trial and the unique challenges in treating acute myeloid leukemia. The conversations explore crucial studies on drug responses in children versus adults, and advancements in CAR-T therapy. Insights into managing relapsed acute lymphoblastic leukemia showcase new strategies aimed at improving outcomes for young patients facing these formidable challenges.
